Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests coaching to ease cancer fear in survivors

NCT ID NCT07228637

Symptom relief Sponsor: Indiana University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a videoconference-based coaching program for testicular cancer survivors to help reduce fear of cancer recurrence and improve quality of life. About 70 survivors will be randomly assigned to either a coaching program based on Acceptance and Commitment Therapy (ACT) or a standard education/support program. The goal is to see which approach better helps survivors cope with difficult thoughts and feelings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Aug 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 18 years of age * Diagnosed with testicular cancer (any type, stage, or risk category) without evidence of active distant disease at time of study entry * Completed surgery, chemotherapy, radiation therapy, and/or stem cell transplant 5 years or less prior to enrollment * Willing to provide authorization to be contacted by email * Willing to complete surveys * Willing to participate in six, 90-minute intervention sessions * Able to speak and read English * Has clinically significant fear of cancer recurrence (FCR-4 score = 9 or higher) and/or anxiety (GAD-2 score = 3 or higher) at eligibility screening Exclusion Criteria: * Completed surgery, chemotherapy, radiation therapy, and/or stem cell transplant less than 2 weeks prior to enrollment (excluding to avoid acute toxicity side effects of treatment) * Patient has co-morbidities or deficits that would impair participation in the study, including: 1. history of neurological disorder or traumatic brain injury (e.g., stroke, encephalitis, epilepsy, loss of consciousness greater than 10 minutes); 2. severe depressive symptoms (PHQ-2 score = 5 or higher at screening), 3. active substance abuse or uncontrolled bipolar disorder, schizophrenia, or psychosis; 4. obvious hearing and/or communicative disability that would impair their participation * Patient is currently participating in "The Platinum Study" (PI: Lois Travis) * Currently participating in psychotherapy focused on cancer-specific adjustment/support * Currently participating in any behavioral/psychosocial research study that has the potential to skew results of this study or the study in which the survivor is participating

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Testicular cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder testicular cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Testicular cancer

Contacts and locations

Locations

  • Indiana University - Indianapolis

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.